The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict athenahealth's revenues will expand 43.1% and EPS will shrink -8.3%.
The average estimate for revenue is $148.1 million. On the bottom line, the average EPS estimate is $0.22.
Last quarter, athenahealth notched revenue of $125.6 million. GAAP reported sales were 30% higher than the prior-year quarter's $96.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.38. GAAP EPS of $0.02 for Q1 were 71% lower than the prior-year quarter's $0.07 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 57.7%, 210 basis points worse than the prior-year quarter. Operating margin was -4.9%, much worse than the prior-year quarter. Net margin was 0.6%, 190 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $597.5 million. The average EPS estimate is $1.10.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 201 members out of 256 rating the stock outperform, and 55 members rating it underperform. Among 73 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 61 give athenahealth a green thumbs-up, and 12 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on athenahealth is hold, with an average price target of $91.54.
Is athenahealth the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add athenahealth to My Watchlist.